Original ArticleInternational Journal of Pharmaceutical InvestigationVol. 14 | Issue 4 | 2024 | pp. 1201–1207Open access
Targeted Immunization Strategies and Designing Vaccine against Indian Nipah Virus Strain (NiV B) and Malaysian Variant (NiV M)
- 1,
- 1*,
- 2*,
- 1,
- 3,
- 4,
- 1,
- 1,
- 2
- 1 Department of Microbiology, Pasteur Institute of India, Coonoor, The Nilgiris, Tamil Nadu, INDIA.
- 2 Centre for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, INDIA.
- 3 Department of Biochemistry, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, Tamil Nadu, INDIA.
- 4 Department of Nanoscience and Technology, Pondicherry University, Puducherry, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Selvaraj Jagannathan
Department of Microbiology, Pasteur Institute of India, Coonoor, The Nilgiris, Tamil Nadu, INDIA.
Email: seljag2005@gmail.com
Correspondence: Maghimaa Mathanmohun
Centre for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, INDIA.
Email: maghimaamm@gmail.com
Copyright: © 2024 Manuscript Technomedia. This is an open access article.
- Published:
- Sep 27, 2024
- Received:
- Mar 23, 2024
- Accepted:
- Jul 9, 2024
How to cite
Pariyapurath, N. K., Jagannathan, S., Mathanmohun, M., Pillai, S. B., Dhandapani, K., Pachamuthu, R. G., Channappa, S. K., Sakthivel, S., & Namassivayam, H. (2024). Targeted Immunization Strategies and Designing Vaccine against Indian Nipah Virus Strain (NiV B) and Malaysian Variant (NiV M). International Journal of Pharmaceutical Investigation, 14(4), 1201–1207. https://doi.org/10.5530/ijpi.14.4.131
Abstract
Background
Nipah virus is a deadly infectious virus that was first isolated and identified from Malaysia. Since then, a number of Nipah virus outbreaks have been reported from Bangladesh and India. Transmission of the disease occurs through Pteropus genus fruit bats. The case fatality rate of this infection is very high when compared with other viral zoonoses. At present, there are no approved vaccines or drugs available to prevent or treat this infection. A number of studies are ongoing to develop an efficient vaccine candidate to combat this deadly virus. The majority of them concentrate on the structural and non-structural proteins, which are the main targets of neutralizing antibodies.
Materials and Methods
Here, we analyzed the genome sequence identity of two Nipah virus strains, Indian and Malaysian, and also the amino acid identity between the two structural proteins (Attachment glycoprotein G and Fusion protein F) and one non-structural protein (W protein) of those two strains.
Results and Discussion
It was found that there is a considerable amount of nucleotide sequence homology between the initial strain that originated from Malaysia and the strain that is now found in India. Furthermore, the Structural and Non-structural proteins of these two strains exhibit a high degree of similarity.
Conclusion
Hence, a vaccine candidate designed using either NiV M or NiV B can be effectively used as a potent vaccine.
Keywords
Subject
Article metadata
| Title | Targeted Immunization Strategies and Designing Vaccine against Indian Nipah Virus Strain (NiV B) and Malaysian Variant (NiV M) |
|---|---|
| Authors | Naseera Kannanthodi Pariyapurath; Selvaraj Jagannathan; Maghimaa Mathanmohun; Sarika Baburajan Pillai; Kavitha Dhandapani; Rahul Gandhi Pachamuthu; Shivanandappa Kukkaler Channappa; Sivakumar Sakthivel; Hemapriya Namassivayam |
| Affiliations | Department of Microbiology, Pasteur Institute of India, Coonoor, The Nilgiris, Tamil Nadu, INDIA.; Centre for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, INDIA.; Department of Biochemistry, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore, Tamil Nadu, INDIA.; Department of Nanoscience and Technology, Pondicherry University, Puducherry, INDIA. |
| Corresponding author | seljag2005@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 14, Issue 4 (2024) |
Also in this issue
- Tumor Invasion and Metastasis: A Current and Emerging Therapeutic Approachespp. 983–997
- An In-depth Review of Exploring the Potential of Colloidosomes in Drug Delivery pp. 998–1009
- Precision Medicine: Unveiling Progress Amidst Challengespp. 1010–1018
- Quality System Requirements of Dietary Supplements: An Overview of 21 CFR Part 111pp. 1019–1024
- Exploring the Therapeutic Potential of Selenium Nanoparticles in Central Nervous System Disorders: A Nanomedicine Approachpp. 1025–1034
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026